Premium

Broker Stifel upgraded its rating on toothpaste-maker Colgate from ‘hold to ‘buy’. The consensus mean price target on CL is US$81.94 and the mean recommendation rating stands at 2.4.

Broker Needham raised its ratings on semiconductor manufacturers Applied Materials and Lam Research Corp. from ‘neutral’ to ‘buy’. The consensus mean price target on AMAT is US$ 155.46, and that on LRCX is US$ 680.14.

Broker BofA raised its rating on Target Corp from ‘neutral’ to ‘buy’ and renewed its price target on the stock. BofA’s updated price target on TGT is US$135, which is 22% higher than Thursday’s closing price.

Brokers initiated coverage on Neumora Therapeutics and gave the stock a buy rating. The positive sentiment on the stock is largely based on the promising outlook surrounding its drug navacaprant.

Broker BofA raised its price target on Eli Lilly on promising prospects surrounding the company’s obesity treatment drug. After the increase, LLY’s share price surged 2.3%, ending trade at US$565.22 on Friday.

Broker RBC initiated coverage on Johnson & Johnson, stating that JNJ’s current trading levels is in line with historical multiples. The broker also gave JNJ a price target of US$178.

Broker UBS raised its price target on Flour Corporation as it believes that Flour’s potential has been underappreciated by investors. The broker also raised the rating on FLR from ‘neutral’ to ‘buy’.